Paradigm BioCapital International Fund Ltd.
SEC CIK 1854392 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | 10% | 6.59M | $1.16M | — | 1 | 2023-12-06 | 2023-12-06 |
Most active insiders at OLMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CLARK IAN T | Dir | — | $7.87M |
| 2 | Zojwalla Naseem | Chief Medical Off | — | $7.53M |
| 3 | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | — | $4.66M |
| 4 | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | — | $2.98M |
| 5 | Mitchell Shawnte | CLO | — | $951.5K |
| 6 | Harmon Cyrus | Dir | — | $743.8K |
| 7 | Austin Sasha Lu | VP of Fin, Ctrl | — | — |
| 8 | Bohen Sean | Pres, CEO, Dir | — | — |
| 9 | RAPPAPORT ANDREW | Dir | — | — |
Paradigm BioCapital International Fund Ltd. made no open-market trades at OLMA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-08 | 2023-12-06 | OLMA | Olema Pharmaceuticals, Inc. | Paradigm BioCapital International Fund Ltd. | 10% | P - Purchase | $11.60 | +100.0K | 6.59M | +2% | +$1.16M |
Purchase Sale Sale after option exercise All abbreviations